Initiation and dose optimization for levodopa-carbidopa intestinal gel: Insights from phase 3 clinical trials

Lew, Mark F.; Slevin, John T.; Krueger, Rejko; Martinez Castrillo, Juan Carlos; Chatamra, Krai; Dubow, Jordan S.; Robieson, Weining Z.; Benesh, Janet A.; Fung, Victor S. C.

dc.contributor.author	Krüger, Rejko
dc.date.accessioned	2015-09-30T13:30:49Z
dc.date.available	2015-09-30T13:30:49Z
dc.date.issued	2015
dc.identifier.issn	1353-8020
dc.identifier.uri	http://hdl.handle.net/10900/65221
dc.language.iso	en	en
dc.publisher	Elsevier Sci Ltd	de_DE
dc.relation.uri	http://dx.doi.org/10.1016/j.parkreldis.2015.04.022	de_DE
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	610	de_DE
dc.title	Initiation and dose optimization for levodopa-carbidopa intestinal gel: Insights from phase 3 clinical trials	de_DE
dc.type	Article	de_DE
utue.quellen.id	20150901145020_00241
utue.publikation.seiten	742-748	de_DE
utue.personen.roh	Lew, Mark F.
utue.personen.roh	Slevin, John T.
utue.personen.roh	Krueger, Rejko
utue.personen.roh	Martinez Castrillo, Juan Carlos
utue.personen.roh	Chatamra, Krai
utue.personen.roh	Dubow, Jordan S.
utue.personen.roh	Robieson, Weining Z.
utue.personen.roh	Benesh, Janet A.
utue.personen.roh	Fung, Victor S. C.
dcterms.isPartOf.ZSTitelID	Parkinsonism & Related Disorders	de_DE
dcterms.isPartOf.ZS-Issue	7	de_DE
dcterms.isPartOf.ZS-Volume	21	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE